~~<i id='74322A5ABD'><strike id='74322A5ABD'><tt id='74322A5ABD'><pre id='74322A5ABD'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

leisure time

author：leisure time 2025-09-30 20:35:17 - browse：32

Adam's take main illustration — Molly Ferguson/STAT

Shares of Apellis Pharmaceuticals are rebounding, driven by a growing belief among some investors that the serious safety issue that has derailed Syfovre, the company’s eye disease treatment, is receding.

Declaring the crisis over is premature, but that could change with more uneventful weeks. Apellis has been a takeout target before, and may be again, at an acquisition price nearly twice its current market value.

Apellis shares rose 32% last week, with most of the gains coming Friday on heavy trading volume. The reason: There have been no new cases of retinal occlusive vasculitis, or ROV, reported in people receiving injections of Syfovre.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： The haunting brain science of long Covid

knowledge

entertainment

leisure time

focus

entertainment

Thefinancechiefofthecountry’slargestprivatepsychiatrichospitaloperator,UHS,madeabluntstatementtoday:

WSS

Harvard scientists, with Google, unveil the most detailed brain map ever

Former reverend arrested for allegedly killing 8

Russian fighter jet damages US Reaper drone with flare over Syria: Officials

Bronny James, LeBron's son, suffers cardiac arrest during basketball practice at USC

Scientific mystery highlights the blind spots in genomics databases

Former reverend arrested for allegedly killing 8

focus

leisure time

knowledge

23andMe had bad news about my health. I wish a person had delivered it

CDC Director Mandy Cohen on transparency, trust, and health

State Dept. review finds Biden bears some blame for Afghanistan failures

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

How to save PrEP access — and even expand it

Multiple sclerosis has subtypes with different best treatments: study

Guidelines to prevent youth baseball injuries need more muscle

Bird flu in dairy cattle: New measures to control spread to humans

Tori Bowie and the unacceptable rates of Black maternal death

Scientists uncover potential path to treating deadly childhood tumor

entertainment

Former reverend arrested for allegedly killing 8

Republican states more likely to report Covid vaccine side effects

Insurer loopholes limit power of law against surprise medical bills

Study: Black kids more likely to die after surgery than white kids

Will the FTC rein in IQVIA's health data empire?

CDC Director Mandy Cohen on transparency, trust, and health

leisure time

focus

focus

entertainment